Soleno Therapeutics Stock Market Value
| SLNO Stock | USD 37.50 0.35 0.94% |
| Symbol | Soleno |
Soleno Therapeutics Price To Book Ratio
Is Soleno Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.36) | Return On Assets (0.23) | Return On Equity (0.46) |
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Soleno Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Soleno Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Soleno Therapeutics.
| 04/26/2023 |
| 04/20/2024 |
If you would invest 0.00 in Soleno Therapeutics on April 26, 2023 and sell it all today you would earn a total of 0.00 from holding Soleno Therapeutics or generate 0.0% return on investment in Soleno Therapeutics over 360 days. Soleno Therapeutics is related to or competes with AnnexonInc, Bolt Biotherapeutics, Lyra TherapeuticsInc, Pulmatrix, Capricor Therapeutics, Akari Therapeutics, and Bio Path. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization ... More
Soleno Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Soleno Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Soleno Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 15.94 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 3.9 |
Soleno Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Soleno Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Soleno Therapeutics' standard deviation. In reality, there are many statistical measures that can use Soleno Therapeutics historical prices to predict the future Soleno Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.21) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Soleno Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Soleno Therapeutics Backtested Returns
Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Soleno Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Soleno Therapeutics' Variance of 9.06, coefficient of variation of (1,318), and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide. The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. Soleno Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Soleno Therapeutics is expected to follow. Soleno Therapeutics has an expected return of -0.35%. Please make sure to validate Soleno Therapeutics total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Soleno Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Soleno Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Soleno Therapeutics time series from 26th of April 2023 to 23rd of October 2023 and 23rd of October 2023 to 20th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Soleno Therapeutics price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Soleno Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 74.34 |
Soleno Therapeutics lagged returns against current returns
Autocorrelation, which is Soleno Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Soleno Therapeutics' stock expected returns. We can calculate the autocorrelation of Soleno Therapeutics returns to help us make a trade decision. For example, suppose you find that Soleno Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Soleno Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Soleno Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Soleno Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Soleno Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Soleno Therapeutics Lagged Returns
When evaluating Soleno Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Soleno Therapeutics stock have on its future price. Soleno Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Soleno Therapeutics autocorrelation shows the relationship between Soleno Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Soleno Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:Check out Soleno Therapeutics Correlation, Soleno Therapeutics Volatility and Soleno Therapeutics Alpha and Beta module to complement your research on Soleno Therapeutics. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Soleno Stock analysis
When running Soleno Therapeutics' price analysis, check to measure Soleno Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soleno Therapeutics is operating at the current time. Most of Soleno Therapeutics' value examination focuses on studying past and present price action to predict the probability of Soleno Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soleno Therapeutics' price. Additionally, you may evaluate how the addition of Soleno Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance |
Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.